SS-31
Research use only.
SS-31 (Elamipretide) is a mitochondria-targeting peptide widely studied for its ability to selectively interact with cardiolipin in the inner mitochondrial membrane. In research settings, SS-31 has gained attention for its role in supporting mitochondrial integrity, improving energy production efficiency, and reducing oxidative stress.
Product overview
SS-31 is a research-grade tetrapeptide engineered to penetrate cell membranes and localize within mitochondria. Preclinical and clinical research associate SS-31 with stabilization of mitochondrial structure, improved electron transport chain function, and reduction of reactive oxygen species (ROS) production. Its targeted mechanism makes it a valuable tool for studying mitochondrial dysfunction and age-related cellular decline.
Key research features
Mitochondrial protection and efficiency:
SS-31 is widely investigated for its ability to stabilize mitochondrial membranes and enhance ATP production, making it central to studies of cellular energy and function.
Oxidative stress and cellular resilience:
Studies suggest SS-31 may reduce oxidative damage by limiting reactive oxygen species formation, supporting research into aging, inflammation, and cellular stress responses.
Cellular energy and performance pathways:
Research indicates SS-31 may improve overall mitochondrial bioenergetics, making it relevant in experimental models focused on endurance, metabolic efficiency, and organ function.
SS-31 (Elamipretide) – Suggested Use (Research Context)
Typical Dose: 1–5 mg per day
Route: Subcutaneous injection
Frequency: Once daily
Duration: As directed by a qualified professional